Analysts Eye ResMeds Sleep Tech Dominance What the Ratings Suggest Elevation Capital Offloads Rs 964 Crore in Paytm Shares via Block Deals Zscaler Shares Tumble After Weak Guidance Sales Restructuring Sparks Concern Pixel Launch Raises Privacy Questions as Google Assistants AI Learns More Japans Megabanks Enjoy Record Profits but Analysts Warn of Slowing Growth Amid Rising Risks China Calls for APEC Economic Cooperation as Commerce Minister Skips Meeting Over Urgent Official Business ZBIO Q1 2026 Earnings EPS Beat Offers Little Lift as No Revenue and Stock Decline Persist HNNA Q1 2026 Earnings Solid Earnings Per Share Amid Quiet Quarter ATLCP Q1 2026 Earnings Preferred Stock Delivers Significant EPS Surprise DMC Global BOOM Q1 2026 Earnings NarrowerThanExpected Loss Supports Modest Stock Gain ABTC Q1 2026 Earnings Massive EPS Miss Triggers Share Price Decline TV Q1 2026 Earnings Massive EPS Surprise Amid Revenue Discrepancy BrandywineGLOBAL Global Income Opportunities Fund BWG Edges Lower Testing Support Zone Tapestry Inc Holds Steady Near 139 as Traders Eye Key Levels MarketAxess MKTX Navigates Narrow Trading Range Amid Quiet Session Solarius Capital Acquisition Corp SOCA Holds Steady Near Key Support Analysis Gravity Co GRVY Sees Minor Decline as Stock Consolidates Near Key Support Levels US Consumer Sentiment Remains Pessimistic Amid Inflation Geopolitical Risks and Trade Policies Nationwide Faces Governance Concerns as Labour MP Calls for Reform Ahead of AGM Trump Administration Policy Would Require Foreigners to Leave US for Green Card Applications Raising Business Concerns Jamie Dimons Latest Message May Signal Challenges for JPMorgan Bankers Northland Raises Price Target on PDF Solutions Following Strong Quarterly Performance Indias Renewable Energy Sector Faces Grid Integration Headwinds in Q1 2026 Despite 275 GW Capacity Milestone Canadian Big Banks Poised for Solid Q2 Results but Cautious Outlook Amid Soft Economic Backdrop CGEN Q1 2026 Earnings EPS Misses Estimates but Stock Rises 728 on Pipeline Progress Aclaris Therapeutics ACRS Edges Higher Testing Resistance After Modest Uptick